메뉴 건너뛰기




Volumn 25, Issue 4, 2009, Pages 951-959

Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension

Author keywords

Aliskiren; Amlodipine; Calcium channel blocker; Combination drug therapy; Direct renin inhibitor; Hypertension; Safety

Indexed keywords

ALISKIREN; AMLODIPINE; ANALGESIC AGENT; ANILIDE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; SALICYLIC ACID DERIVATIVE;

EID: 67649306830     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990902785845     Document Type: Article
Times cited : (62)

References (20)
  • 3
    • 0025805484 scopus 로고
    • Effects of amlodipine on urinary sodium excretion, renin-angiotensin- aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension
    • Cappuccio FP, Markandu ND, Sagnella GA, et al. Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension. J Hum Hypertens 1991;5:115-119
    • (1991) J Hum Hypertens , vol.5 , pp. 115-119
    • Cappuccio, F.P.1    Markandu, N.D.2    Sagnella, G.A.3
  • 6
    • 52049097072 scopus 로고    scopus 로고
    • Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes
    • Imanishi T, Tsujioka H, Ikejima H, et al. Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Hypertension 2008;52:563-572
    • (2008) Hypertension , vol.52 , pp. 563-572
    • Imanishi, T.1    Tsujioka, H.2    Ikejima, H.3
  • 7
    • 28744436699 scopus 로고    scopus 로고
    • Antioxidant and nitric oxide-sparing actions of dihydropyridines and ACE inhibitors differ in human endothelial cells
    • DOI 10.1159/000088854
    • Lob H, Rosenkranz AC, Breitenbach T, et al. Antioxidant and nitric oxide-sparing actions of dihydropyridines and ACE inhibitors differ in human endothelial cells. Pharmacology 2006;76:8-18 (Pubitemid 41759057)
    • (2006) Pharmacology , vol.76 , Issue.1 , pp. 8-18
    • Lob, H.1    Rosenkranz, A.C.2    Breitenbach, T.3    Berkels, R.4    Drummond, G.5    Roesen, R.6
  • 8
    • 0036016107 scopus 로고    scopus 로고
    • Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- And kinin-dependent mechanism
    • Xu B, Xiao-Hong L, Lin G, et al. Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- and kinin-dependent mechanism. Br J Pharmacol 2002;136:375-382 (Pubitemid 34620518)
    • (2002) British Journal of Pharmacology , vol.136 , Issue.3 , pp. 375-382
    • Xu, B.1    Xiao-hong, L.2    Lin, G.3    Queen, L.4    Ferro, A.5
  • 9
    • 34547925543 scopus 로고    scopus 로고
    • Aliskiren: A review of its use in the management of hypertension
    • DOI 10.2165/00003495-200767120-00008
    • Frampton JE, Curran MP. Aliskiren: a review of its use in the management of hypertension. Drugs 2007;67:1767-1792 (Pubitemid 47263181)
    • (2007) Drugs , vol.67 , Issue.12 , pp. 1767-1792
    • Frampton, J.E.1    Curran, M.P.2
  • 10
    • 53349092083 scopus 로고    scopus 로고
    • Direct renin inhibition: An evaluation of the safety and tolerability of aliskiren
    • Rashid H. Direct renin inhibition: an evaluation of the safety and tolerability of aliskiren. Curr Med Res Opin 2008;24:2627-2637
    • (2008) Curr Med Res Opin , vol.24 , pp. 2627-2637
    • Rashid, H.1
  • 11
    • 36248931230 scopus 로고    scopus 로고
    • Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy
    • Drummond W, Munger MA, Essop MR, et al. Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy. J Clin Hypertens 2007;9:742-750
    • (2007) J Clin Hypertens , vol.9 , pp. 742-750
    • Drummond, W.1    Munger, M.A.2    Essop, M.R.3
  • 12
    • 0033953234 scopus 로고    scopus 로고
    • Amlodipine, enalapril, and dependent leg edema in essential hypertension
    • Pedrinelli R, Dell'Omo G, Melillo E, et al. Amlodipine, enalapril, and dependent leg edema in essential hypertension. Hypertension 2000;35:621-625 (Pubitemid 30108158)
    • (2000) Hypertension , vol.35 , Issue.2 , pp. 621-625
    • Pedrinelli, R.1    Dell'Omo, G.2    Melillo, E.3    Mariani, M.4
  • 13
    • 0642274210 scopus 로고    scopus 로고
    • Incidence of pedal edema formation with dihydropyridine calcium channel blockers: Issues and practical significance
    • Greenwich
    • Weir MR. Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance. J Clin Hypertens (Greenwich) 2003;5:330-335
    • (2003) J Clin Hypertens , vol.5 , pp. 330-335
    • Weir, M.R.1
  • 14
    • 67649345134 scopus 로고    scopus 로고
    • E1: The extent of population exposure to assess clinical safety for drugs intended for long-term treatment of non-life-threatening conditions
    • International Conference on Harmonization
    • International Conference on Harmonization. E1: The extent of population exposure to assess clinical safety for drugs intended for long-term treatment of non-life-threatening conditions. In: International Conference on Harmonization, 1994
    • International Conference on Harmonization, 1994
  • 15
    • 67649331137 scopus 로고    scopus 로고
    • Long-term safety and efficacy of combination therapy with amlodipine and valsartan in hypertensive patients
    • Abstract P-70
    • Smith TR, Glazer R, Koren MJ, et al. Long-term safety and efficacy of combination therapy with amlodipine and valsartan in hypertensive patients. J Clin Hypertens 2008;10:A35 (Abstract P-70)
    • (2008) J Clin Hypertens , vol.10
    • Smith, T.R.1    Glazer, R.2    Koren, M.J.3
  • 16
    • 43549100189 scopus 로고    scopus 로고
    • The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study
    • DOI 10.1016/j.clinthera.2008.04.002, PII S0149291808001410
    • Chrysant SG, Melino M, Karki S, et al. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. Clin Ther 2008;30:587-604 (Pubitemid 351680489)
    • (2008) Clinical Therapeutics , vol.30 , Issue.4 , pp. 587-604
    • Chrysant, S.G.1    Melino, M.2    Karki, S.3    Lee, J.4    Heyrman, R.5
  • 17
    • 60549087324 scopus 로고    scopus 로고
    • Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: A 12-month randomized, double-blind comparator trial with hydrochlorothiazide
    • Schmieder RE, Philipp T, Guerediaga J, et al. Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide. Circulation 2009;119:417-425
    • (2009) Circulation , vol.119 , pp. 417-425
    • Schmieder, R.E.1    Philipp, T.2    Guerediaga, J.3
  • 18
    • 2642547176 scopus 로고    scopus 로고
    • Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension
    • DOI 10.1016/j.amjhyper.2004.02.003, PII S0895706104000408
    • Jamerson KA, Nwose O, Jean-Louis L, et al. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Am J Hypertens 2004;17:495-501 (Pubitemid 38726163)
    • (2004) American Journal of Hypertension , vol.17 , Issue.6 , pp. 495-501
    • Jamerson, K.A.1    Nwose, O.2    Jean-Louis, L.3    Schofield, L.4    Purkayastha, D.5    Baron, M.6
  • 19
    • 67649326611 scopus 로고    scopus 로고
    • Effect of telmisartan addition to amlodipine on reduction of incidence of peripheral oedema: Safety analysis from a factorial study in hypertension
    • Abstract P-51
    • Littlejohn T, Majul C, Oigman W, et al. Effect of telmisartan addition to amlodipine on reduction of incidence of peripheral oedema: safety analysis from a factorial study in hypertension. J Clin Hypertens 2008;10:A27 (Abstract P-51)
    • (2008) J Clin Hypertens , vol.10
    • Littlejohn, T.1    Majul, C.2    Oigman, W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.